Open Access

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway

  • Authors:
    • Xiong Shu
    • Huiqi Liu
    • Rui Zhen
    • Yongsheng Jie
    • Lei Chen
    • Hui Qi
    • Chao Wang
    • Renxian Wang
    • Dafu Chen
    • Yuliang Ran
  • View Affiliations

  • Published online on: June 21, 2023     https://doi.org/10.3892/or.2023.8593
  • Article Number: 156
  • Copyright : © Shu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 44: [Related article:] 313–324, 2020; DOI: 10.3892/or.2020.7597

Following the publication of the article, a concerned reader drew to the authors' attention that, in Fig. 1B and C on p. 316, two pairs of the data panels showing the results from invasion and migration assay experiments appeared to be overlapping, such that they would have been derived from the same original sources where they were intended to show the results from different experiments; moreover, on p. 1698, the ‘17-AAG / MG-63’ data panels in Fig. 3B and C were also overlapping, albeit the images were presented at a different scale and in a slightly different orientation.

After having examined their original data, the authors have realized that these figures were inadvertently assembled incorrectly. The corrected versions of Figs. 1 and 3, now showing the correct data in Fig. 1C (where the errors made in compiling the figure had occurred) and the correct data for the ‘17-AAG / MG-63’ data panel in Fig. 3C, are shown on the next two pages. These corrections do not grossly affect either the results or the conclusions reported in this work. The authors all agree to the publication of this Corrigendum, and are grateful to the Editor of Oncology Reports for granting them the opportunity to correct the errors that were made during the assembly of these figures. Lastly, the authors apologize to the readership for any inconvenience these errors may have caused.

Related Articles

Journal Cover

August-2023
Volume 50 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shu X, Liu H, Zhen R, Jie Y, Chen L, Qi H, Wang C, Wang R, Chen D, Ran Y, Ran Y, et al: [Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway. Oncol Rep 50: 156, 2023
APA
Shu, X., Liu, H., Zhen, R., Jie, Y., Chen, L., Qi, H. ... Ran, Y. (2023). [Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway. Oncology Reports, 50, 156. https://doi.org/10.3892/or.2023.8593
MLA
Shu, X., Liu, H., Zhen, R., Jie, Y., Chen, L., Qi, H., Wang, C., Wang, R., Chen, D., Ran, Y."[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway". Oncology Reports 50.2 (2023): 156.
Chicago
Shu, X., Liu, H., Zhen, R., Jie, Y., Chen, L., Qi, H., Wang, C., Wang, R., Chen, D., Ran, Y."[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway". Oncology Reports 50, no. 2 (2023): 156. https://doi.org/10.3892/or.2023.8593